未登录

Y

Young Sup Woo

hanyang university

H指数:26

被引数:2,470

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparative efficacy and safety of liraglutide versus metformin, naltrexone/bupropion, and phentermine-topiramate in psychiatric patients

利拉鲁肽与二甲双胍、纳曲酮/安非他酮以及芬特明-托吡酯在精神科患者中的疗效与安全性比较

Therapeutic Advances in Psychopharmacology

IF4

2026-02-180

PRE

Korean Medication Algorithm Project for Depressive Disorder 2025: with Other Treatment Guidelines

韩国抑郁症药物治疗算法项目2025：与其他治疗指南

Clinical Psychopharmacology and Neuroscience

IF2.7

2026-02-010

PRE

Korean Medication Algorithm for Depressive Disorder 2025, Fifth Revision: An Executive Summary

CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE

IF2.7

2025-11-010

PRE

Korean Medication Algorithm Project for Bipolar Disorder 2022: Treatment Strategy According to Safety and Tolerability

EUROPEAN PSYCHIATRY

IF6.7

2024-08-270

OAAI

Preventive effect of aripiprazole once-monthly on relapse into mood episodes in bipolar disorder: A multicenter, one-year, retrospective, mirror image study

JOURNAL OF AFFECTIVE DISORDERS

IF4.9

2024-04-011

OAAI

Amisulpride Augmentation in Schizophrenia Patients with Poor Response to Olanzapine: A 4-week, Randomized, Rater-Blind, Controlled, Pilot Study

EUROPEAN PSYCHIATRY

IF6.7

2023-07-190

OAAI

The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD): Changes in Preferred Treatment Strategies and Medications over 20 Years and Five Editions

JOURNAL OF CLINICAL MEDICINE

IF2.9

2023-02-011

OAAI

A Comparative Study on the Predictive Value of Different Resting-State Functional Magnetic Resonance Imaging Parameters in Preclinical Alzheimer's Disease

不同静息态功能磁共振成像参数对临床前阿尔茨海默病预测价值的对比研究

FRONTIERS IN PSYCHIATRY

IF3.2

2021-06-116

OAAI

The Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP): Changes in preferred treatment strategies and medications over 16 years and five editions

BIPOLAR DISORDERS

IF4.5

2020-04-064

PREAI

Associations among immune activation, the clinical characteristics, and the current severity of the with anxious distress specifier in patients with depressive disorders

EUROPEAN PSYCHIATRY

IF6.7

2020-03-230

OAAI

Factors related to suicidal behavior in korean patients with bipolar disorder: The effect of mixed features on suicidality

EUROPEAN PSYCHIATRY

IF6.7

2020-03-230

OAAI

Blonanserin augmentation in patients with schizophrenia - who is benefited from blonanserin augmentation?: An open-label, prospective, multicenter study

EUROPEAN PSYCHIATRY

IF6.7

2020-03-230

PREAI

Adaptation and validation of the Korean Version of the Bipolar Depression Rating Scale (K-BDRS)

EUROPEAN PSYCHIATRY

IF6.7

2020-03-231

PREAI

Korean medication algorithm for depressive disorder (KMAP-DD) 2017: Maintenance treatment

EUROPEAN PSYCHIATRY

IF6.7

2020-03-230

PREAI

Determining the cut-off for recurrent depressive episode to predict diagnostic conversion from unipolar depression to bipolar disorder: 5-year retrospective study in one university hospital

EUROPEAN PSYCHIATRY

IF6.7

2020-03-230

OAAI

Nicotinic acetylcholine receptor antagonists for treatment-resistant depression: A meta-analysis

EUROPEAN PSYCHIATRY

IF6.7

2020-03-230

PREAI

Efficacy and safety of generic escitalopram (Lexacure) in patients with major depressive disorder: A 6-week, multi-center, randomized, rater-blinded, escitalopram-comparative, non-inferiority study

EUROPEAN PSYCHIATRY

IF6.7

2020-03-230

PREAI

Willingness-to-pay of patients with chronic skin diseases: A pilot study

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2019-09-010

OAAI

A COMPARISON BETWEEN OLANZAPINE CONTINUATION AND AMISULPRIDE COMBINATION IN ACUTE SCHIZOPHRENIA PATIENTS SHOWING EARLY NON-RESPONSE TO OLANZAPINE: 4-WEEKS, RANDOMIZED, RATER-BLINDED PILOT STUDY

SCHIZOPHRENIA BULLETIN

IF4.8

2019-04-090

OAAI

Use of a smartphone application to screen for depression and suicide in South Korea

GENERAL HOSPITAL PSYCHIATRY

IF3.7

2017-05-018

PREAI